55498 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 

commercialize these organic 

thiophosphate antiretroviral agents. 

Please contact Betty Tong, PhD at 301/ 

594–4263 or tongb@mail.nih.gov for 

more information. 

Dated: September 18, 2006. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. 06–8082 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

H—Clinical Groups, NCI Subcommittee H—

Clinical Trials. 

Date: October 24–25, 2006. 

Time: 7 p.m. to 2 p.m. 

Agenda: To review and evaluate 

cooperative agreement applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., MIRAGE I & II, 

Washington, DC 20007. 

Contact Person: Timothy C. Meeker, MD, 

PhD, Scientific Review Administrator, 

Resources and Training Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, 6116 Executive Boulevard, 

Room 8103, Bethesda, MD 20892, (301) 594–

1279, meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NIH Small 

Grants for Cancer Epidemiology and Cancer 

Prevention. 

Date: November 7–9, 2006. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2101 

Wisconsin Avenue, NW., Washington, DC 

20007. 

Contact Person: Irina Gordienko, PhD., 

Scientific Review Administrator, Scientific 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Rm. 

7073, Bethesda, MD 20892, 301–594–1566, 

gordienkoiv@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8087 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, SBIR 

Topics 210 and 213. 

Date: October 26, 2006. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: NIH Events Management, Executive 

Plaza North, 6130 Executive Boulevard, 

Conference Room C, Rockville, MD 20852, 

(Telephone Conference Call). 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, 6116 Executive 

Boulevard, Room 7073, MSC8329, Bethesda, 

MD 20892–8329, 301–496–0694, 

msalin@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8092 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552(b)(c)(4) and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Institute of 

Alcohol Abuse and Alcoholism Initial 

Review Group, Biomedical Research Review 

Subcommittee. 

Date: October 12–13, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sathasiva B. Kandasamy, 

Phd, Scientific Review Administrator, Office 

of Scientific Affairs, National Institute on 

Alcohol Abuse & Alcoholism, Extramural 

Review Branch, 5635 Fishers Lane, Bethesda, 

MD 20892–9304, (301) 443–2861, 

skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS) 


sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices 55499 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8084 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research Initial Review Group. 

Date: October 16–17, 2006. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza—Silver Spring, 8777 

Georgia Avenue, Silver Spring, MD 20910. 

Contact Person: Jeffrey M. Chernak, PhD, 

Scientific Review Administrator, Office of 

Review, National Institute of Nursing 

Research, 6701 Domocracy Plaza, Suite 710, 

MSC 4870, Bethesda, MD 20892, (301) 402–

6959, chernak@mail.nih.gov. 

Name of Committee: National Institute of 

Nursing Research Special Emphasis Panel, 

Career Development Award for Research in 

Nursing Studies. 

Date: October 17, 2006. 

Time: 4 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza—Washington Silver 

Spring, 8777 Georgia Avenue, Silver Spring, 

MD 20910. 

Contact Person: Jeffrey M. Chernak, PhD, 

Scientific Review Administrator, Office of 

Review, Division of Extramural Activities, 

National Institute of Nursing Research/NIH, 

6701 Democracy Plaza, Suite 712, MSC 4870, 

Bethesda, MD 20817, (301) 402–6959, 

chernak@nih.gov. 

Name of Committee: National Institute of 

Nursing Research Special Emphasis Panel, 

NINR Institutional Training Grant (T32) 

Applications. 

Date: October 18, 2006. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza—Silver Spring, 8777 

Georgia Avenue, Silver Spring, MD 20910. 

Contact Person: Jeffrey M. Chernak, PhD, 

Scientific Review Administrator, Office of 

Review, Division of Extramural Activities, 

National Institute of Nursing Research/NIH, 

6701 Democracy Plaza, Suite 712, MSC 4670, 

Bethesda, MD 20817, (301) 402–6959, 

chernak@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8086 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group, Health Services, and 

Behavioral Research Review Subcommittee. 

Date: November 1–2, 2006. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Lorraine Gunzerath, PhD, 

MBA, Scientific Review Administrator, 

National Institute on Alcohol Abuse and 

Alcoholism, Office of Extramural Activities, 

Extramural Project Review Branch, 5635 

Fishers Lane, Room 3043, Bethesda, MD 

20892–9304, 301–443–2369, 

lgunzera@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants, 

National Institutes of Health, HHS) 

Dated: September 15, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–8088 Filed 9–21–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse, 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, Health 

Services Research Subcommittee. 

Date: October 4–5, 2006. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Madison Hotel, 1177—15th 

Street, NW., Washington, DC 20005. 

Contact Person: Meenaxi Hiremath, PhD, 

Health Scientist Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, National Institutes of Health, 

DHHS, 6101 Executive Blvd., Suite 220, MSC 

8401, Bethesda, MD 20892, 301–402–7964, 

mh392G@nih. gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute on 

Drug Abuse Initial Review Group, 

Medication Development Research 

Subcommittee. 

Date: October 4, 2006. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott at Metro Center, 775 12th 

Street, NW., Washington, DC 20005. 

Contact Person: Gerald L. McLaughlin, 

Scientific Review Administrator, Office of 

Extramural Affairs, National Institute on 

Drug Abuse, NIH, DHHS, Room 220, MSC 


sroberts on PROD1PC70 with NOTICES